title: Prostaglandin E2 inhibits antidiuretic hormone induced transepithelial sodium transport and cAMP production in frog skin epithelium (Rana esculenta).
abstract: The stimulation of transepithelial sodium transport by arginine vasotocin (AVT) and the ability of prostaglandin E2 (PGE2) to inhibit the AVT dependent sodium transport was examined on pieces of frog skin taken from different regions of the frog. The basal sodium transport was of the same magnitude in the abdominal, thoracal and upper and lower dorsal region. In all regions the sodium transport could be stimulated by AVT, though the stimulation was highest in the abdomen. Subsequent addition of PGE2 caused a significant inhibition of the AVT dependent sodium transport in the abdomen but had only minor effects on the other parts of the skin. Therefore, pieces of skin from the abdomen were selected for the remaining experiments. Addition of PGE2 to skin pieces in the presence of AVT resulted in a hyperpolarization of the cellular potential and a decrease in the transepithelial sodium transport, indicating a decreased apical sodium permeability. This was correlated with a decrease in cellular cAMP contents. We conclude that frog skin exhibits large regional differences in sensitivity to AVT and that PGE2 only modulates the natriferic effect of AVT in the abdomen.
authors.affiliation: Biochemical Department, August Krogh Institute, University of Copenhagen, Denmark.
authors.forename: K A
authors.initials: KA
authors.lastname: Rytved
authors.forename: H
authors.initials: H
authors.lastname: Andersen
authors.forename: R
authors.initials: R
authors.lastname: Nielsen
mesh_terms: D000818:Animals; D000242:Cyclic AMP / Q000032:analysis / Q000096:biosynthesis*; D015232:Dinoprostone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials; D010120:Oxytocics / Q000494:pharmacology*; D010539:Permeability / Q000187:drug effects; D011893:Rana esculenta; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D014668:Vasotocin / Q000037:antagonists & inhibitors*
chemical_list: D010120:Oxytocics; D012964:Sodium; D000242:Cyclic AMP; D015232:Dinoprostone; D014668:Vasotocin